{"entity":{"id":"nct07238075","kind":"trial","name":"ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers","aka":[],"tldr":"A phase 1 trial of ADCX-020 run by Adcytherix SAS, now recruiting.","summary":"ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers is a phase 1 interventional study registered as NCT07238075 by Adcytherix SAS, with 290 participants planned, started 2026-02-23. Conditions recorded: Advanced Malignancy, Advanced Solid Cancers and Metastatic Solid Tumors. Interventions recorded: ADCX-020.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07238075","url":"https://clinicaltrials.gov/study/NCT07238075"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["adcx-020"],"companies":["adcytherix"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07238075","phase":"1","setting":"A First-in-human, Multicenter Dose Escalation and Multiple Cohort Expansion Phase 1a/b Study to Investigate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ADCX-020 in Participants With Locally Advanced or Metastatic Solid Tumors","sponsor":"Adcytherix SAS","enrolled":290,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07238075/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"adcx-020","kind":"drug","name":"ADCX-020","route":"/drugs/adcx-020/"}],"company":[{"id":"adcytherix","kind":"company","name":"Adcytherix","route":"/companies/adcytherix/"}]}}